We are live on ! Find out more

496 hedge funds and large institutions have $12.4B invested in Sanofi in 2014 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 188 increasing their positions, 152 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 38

30% more funds holding in top 10

Funds holding in top 10: 1013 (+3)

24% more repeat investments, than reductions

Existing positions increased: 188 | Existing positions reduced: 152

10% more call options, than puts

Call options by funds: $65.9M | Put options by funds: $59.9M

2% more funds holding

Funds holding: 486496 (+10)

3% more capital invested

Capital invested by funds: $12.1B → $12.4B (+$310M)

0.98% more ownership

Funds ownership: 17%17.98% (+0.98%)

Holders
496
Holders Change
+10
Holders Change %
+2.06%
% of All Funds
14.33%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.38%
New
54
Increased
188
Reduced
152
Closed
38
Calls
$65.9M
Puts
$59.9M
Net Calls
+$6.02M
Net Calls Change
+$454K
Name Holding Trade Value Shares
Change
Change in
Stake
Dodge & Cox
1
Dodge & Cox
California
$2.28B +$1.83M +36,158 +0.1%
Barrow, Hanley, Mewhinney & Strauss
2
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.45B +$260M +5,144,976 +23%
Franklin Resources
3
Franklin Resources
California
$779M +$79.8M +1,576,123 +12%
Fisher Asset Management
4
Fisher Asset Management
Washington
$676M +$5.91M +116,737 +0.9%
Invesco
5
Invesco
Georgia
$602M +$75M +1,480,774 +15%
Boston Partners
6
Boston Partners
Massachusetts
$585M +$32.5M +643,031 +6%
Hotchkis & Wiley Capital Management
7
Hotchkis & Wiley Capital Management
California
$513M +$197M +3,892,219 +66%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$309M -$26.7M -527,780 -8%
NIMC
9
NWQ Investment Management Company
California
$285M -$18.9M -372,705 -6%
Berkshire Hathaway
10
Berkshire Hathaway
Nebraska
$204M
SSM
11
Sound Shore Management
Connecticut
$157M +$27.8M +549,506 +22%
MNA
12
Manning & Napier Advisors
New York
$153M +$132M +2,611,079 +837%
MAA
13
Managed Account Advisors
New Jersey
$150M -$15.7M -310,077 -10%
SGA
14
Sustainable Growth Advisers
Connecticut
$138M +$23.9M +471,996 +22%
Harris Associates
15
Harris Associates
Illinois
$138M +$134M +2,641,500 New
Bessemer Group
16
Bessemer Group
New Jersey
$135M +$7.31M +144,387 +6%
Primecap Management
17
Primecap Management
California
$129M +$9.9M +195,625 +9%
Macquarie Group
18
Macquarie Group
Australia
$115M +$3.51M +69,304 +3%
Bank of America
19
Bank of America
North Carolina
$111M -$5.13M -101,296 -5%
BIP
20
Brandes Investment Partners
California
$108M +$3.01M +59,490 +3%
Morgan Stanley
21
Morgan Stanley
New York
$106M +$16.7M +329,614 +19%
SCCM
22
Schafer Cullen Capital Management
New York
$104M +$6.8M +134,408 +7%
Northern Trust
23
Northern Trust
Illinois
$99.6M +$31M +612,730 +47%
Loomis, Sayles & Company
24
Loomis, Sayles & Company
Massachusetts
$99.3M -$247K -4,881 -0.3%
SI
25
Scharf Investments
California
$97.8M +$5.74M +113,311 +6%

SNY Hedge Fund Activity: Q1 2014 in Review

496 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2014, worth a combined $12.4B — up 2.6% from $12.1B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new SNY positions and 38 closed out — a net gain of 16 holders — while 188 added to existing stakes and 152 trimmed.

The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $260M. The largest seller was UBS, cutting an estimated $158M.

  • 496 institutional investors held Sanofi (SNY) as of Q1 2014, up from 486 in Q4 2013.
  • Funds reported $12.4B of Sanofi stock for Q1 2014, up 2.6% quarter-over-quarter.
  • 54 funds opened new Sanofi positions in Q1 2014 and 38 closed out, a net change of +16 holders.
  • The largest Sanofi buyer in Q1 2014 was Barrow, Hanley, Mewhinney & Strauss, an estimated $260M added.
  • The largest Sanofi seller in Q1 2014 was UBS, an estimated $158M sold.

Based on aggregated 13F filings for Q1 2014.